1. Academic Validation
  2. The N-Acylpolyamine Structure Assigned as Parawixin10 Does Not Display Positive Allosteric Modulatory Activity in EAAT1-3 Radioligand Uptake Assays, nor Does It Enhance Neuronal Survival in Mice in a Dose-Dependent and Statistically Significant Way

The N-Acylpolyamine Structure Assigned as Parawixin10 Does Not Display Positive Allosteric Modulatory Activity in EAAT1-3 Radioligand Uptake Assays, nor Does It Enhance Neuronal Survival in Mice in a Dose-Dependent and Statistically Significant Way

  • ACS Chem Neurosci. 2026 Apr 15;17(8):1530-1539. doi: 10.1021/acschemneuro.5c00943.
Yasaman Doroudian 1 Melissa Schepers 2 3 Tim Vanmierlo 2 3 Lennart Bunch 1
Affiliations

Affiliations

  • 1 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen OE 2100, Denmark.
  • 2 Department of Neuroscience, Biomedical Research Institute, BIOMED, Hasselt University, UHasselt, Diepenbeek 3590, Belgium.
  • 3 Department Psychiatry and Neuropsychology, European Graduate School of Neuroscience, Mental Health and Neuroscience Research Institute, Division of Translational Neuroscience, Maastricht University, Maastricht 6229ER, Netherlands.
Abstract

Enhancing glutamate (Glu) uptake by positive allosteric modulation of excitatory Amino acid Transporter subtype 2 (EAAT2) is an attractive strategy to enable neuroprotection. However, while the EAAT field is rich in reports on inhibitors, enhancing EAAT2 protein dynamics is a much more difficult objective. A natural product approach reported that a spider venom HPLC fraction, number 10, showed neuroprotective effects. It was referred to as parawixin10, and later the structure of the key component responsible for the neuroprotective action was disclosed to be an N-acylamine, compound 2. We have resynthesized the N-acylamine 2 (parawixin10) and show here that this compound does not enhance Glu uptake in a wide range of radioligand binding assays, nor does it, in our hands, show any neuroprotective effect in a dose-dependent, statistically significant way.

Keywords

glutamate; natural products; neuroprotection; neuroscience; positive allosteric modulators; transporters.

Figures
Products